Children and adolescents with obesity and insulin resistance have increased levels of fasting plasma glucagon and GLP-1, increased glucagon, and diminished GLP-1 responses during the OGTT, corresponding with reduced insulin sensitivity and β-cell function. The gene discussed is GLP1R; the disease is Insulin resistance.